Gene Logic

Genetic Technologies Limited, a molecular diagnostics company, provides predictive genetic testing and risk assessment tools to help physicians manage people's health in the United States, Canada, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. It operates in two segments, EasyDNA and GeneType/Corporate. The company offers BREVAGenplus, a clinically validated risk assessment test for non-hereditary breast cancer. It also markets BREVAGenplus to healthcare professionals in breast health care and imaging centers, as well as to obstetricians/gynecologists and breast cancer risk assessment specialists, such as breast surgeons. In addition, the company offers various cancer risk assessment tests under the GeneType for Colorectal Cancer and GeneType for Breast Cancer brand names; and develops other risk assessment tests across a range of diseases, which include colorectal cancer, ovarian cancer, prostate cancer, coronary artery, and type 2 diabetes. Further, it offers genetic testing services, including medical, animal, forensic, and plant testing. The company has research and collaboration agreements with the University of Melbourne, Translational Genomics Research Institute, Memorial Sloan Kettering New York Cambridge University, the Ohio State University, and Shivom. Genetic Technologies Limited was incorporated in 1987 and is headquartered in Fitzroy, Australia.

Founded in 1996, Gene Logic is a publicly traded company that provides genomic and proteomic information, decision support and discovery services for life science and drug development research. Their proprietary research platform combines sophisticated bioinformatics analysis of publicly available and licensed genomic and proteomic databases with their own, patented gene expression and proteomic profiling technology. Through this platform, the company enables life science, biotechnology and pharmaceutical customers to explore complex biological systems and formulate new strategies for drug target discovery.

Gene Logic is committed to providing the most powerful, reliable and comprehensive genomic and proteomic solutions and services to the life science community.

Gene Logic strives to become the premier provider of genomic-and proteomic-based decision support and discovery services to the life-science and drug development research community.

Gene Logic is committed to providing the most powerful, reliable and comprehensive genomic and proteomic solutions and services to the life science community.

Gene Logic strives to become the premier provider of genomic-and proteomic-based decision support and discovery services to the life-science and drug development research community.

Gene Logic

Share

Contacts

Follow Us

Gene Logic

Share

Contacts

Follow Us